Journal of the National Cancer Institute
-
J. Natl. Cancer Inst. · Dec 2011
Randomized Controlled Trial Comparative StudyConcurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
Concurrent chemoradiotherapy (CCRT) has been shown to improve outcomes for stage III-IV nasopharyngeal carcinoma (NPC) patients compared with radiotherapy (RT) alone, but the effectiveness of the combined therapy for stage II NPC patients is unknown. ⋯ Concurrent chemotherapy and radiotherapy is associated with a considerable survival benefit for patients with stage II NPC.